Cargando…
Open peer commentary on “Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions”
Autor principal: | Gandy, Sam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10661216/ https://www.ncbi.nlm.nih.gov/pubmed/38023619 http://dx.doi.org/10.1002/trc2.12437 |
Ejemplares similares
-
Open peer review commentary on building clinically relevant outcomes across the Alzheimer's disease spectrum
por: Rockwood, Kenneth
Publicado: (2021) -
Meaningful benefit and minimal clinically important difference (MCID) in Alzheimer's disease: Open peer commentary
por: Cummings, Jeffrey
Publicado: (2023) -
Prescribing anti‐amyloid immunotherapies to treat Alzheimer's disease: Fully informing patient decisions
por: Greenberg, Barry D., et al.
Publicado: (2023) -
Peer commentary: in vitro gametogenesis: just another way to have a baby
por: Carbone, June
Publicado: (2016) -
Yesterday's war; tomorrow's technology: peer commentary on ‘Ethical, legal, social and policy issues in the use of genomic technologies by the US military’
por: Evans, Nicholas G., et al.
Publicado: (2014)